Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
---|
07/03/2012 | CA2564355C Protein kinase modulators and method of use |
07/03/2012 | CA2509899C Enantiomer (-) of tenatoprazole and the therapeutic use thereof |
07/03/2012 | CA2504153C Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases |
06/28/2012 | WO2012088491A2 Pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same |
06/28/2012 | WO2012088469A1 Faah inhibitors |
06/28/2012 | WO2012088431A1 Faah inhibitors |
06/28/2012 | WO2012088411A1 2-arylimidazo[1,2-b]pyridazine, 2-phenylimidazo[1,2-a]pyridine, and 2-phenylimidazo[1,2-a]pyrazine derivatives |
06/28/2012 | WO2012088124A2 Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof |
06/28/2012 | WO2012088038A2 Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof |
06/28/2012 | WO2012087833A1 Hepatitis c inhibitors and uses thereof |
06/28/2012 | WO2012087784A1 Heterocyclic compounds and their uses |
06/28/2012 | WO2012087782A1 Pyrazolopiperidine compounds as ccr1 receptor antagonists |
06/28/2012 | WO2012087519A1 Compositions and methods for modulating fxr |
06/28/2012 | WO2012086848A1 Fused heterocyclic compound and use for pest control thereof |
06/28/2012 | WO2012086735A1 Condensed heterocyclic compound |
06/28/2012 | WO2012086332A1 Near-infrared absorbing synthetic resin composition |
06/28/2012 | WO2012086241A1 Optically-active diazabicyclooctane derivative and method for manufacturing same |
06/28/2012 | WO2012085857A1 3,8-diaza-bicyclo[4.2.0]oct-3-yl amides |
06/28/2012 | WO2012085852A1 3,8-diaza-bicyclo[4.2.0]oct-8-yl amides |
06/28/2012 | WO2012085167A1 Metabotropic glutamate receptor modulators |
06/28/2012 | WO2012085166A1 Metabotropic glutamate receptor modulators |
06/28/2012 | WO2012060590A3 Hydrate of 1-{(2s)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di- hydropyrido[3,4-d]pyrimidin-7(6h)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate |
06/28/2012 | WO2011156786A8 6-(ethynyl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |
06/28/2012 | US20120165533 Optically active diazabicyclooctane derivatives and process for preparing the same |
06/28/2012 | US20120165532 One-Step Synthesis Method of 2,9-Dimethyl-4,7-Diphenyl-1,10- Phenanthroline |
06/28/2012 | US20120165531 Tricyclic N-heteroaryl-carboxamide derivatives, preparation and therapeutic use thereof |
06/28/2012 | US20120165530 Naphthalene monoimide derivatives and use thereof as photosensitizers in solar cells and photodetectors |
06/28/2012 | US20120165527 process for the preparation of pure paliperidone |
06/28/2012 | US20120165368 Pyrazolopyridine kinase inhibitors |
06/28/2012 | US20120165367 Azaindazoles useful as inhibitors of kinases |
06/28/2012 | US20120165356 Spirocyclic heterocyclic derivatives and methods of their use |
06/28/2012 | US20120165347 Compounds and their use as BACE Inhibitors |
06/28/2012 | US20120165331 Di/tri-aza-spiro-C9-C11alkanes |
06/28/2012 | US20120165327 Spiropiperidines for use as tryptase inhibitors |
06/28/2012 | US20120165322 Rho kinase inhibitors |
06/28/2012 | US20120165321 Quinoline derivatives as pi3 kinase inhibitors |
06/28/2012 | US20120165318 Heterocyclic compounds for the inhibition of pask |
06/28/2012 | US20120165313 Pyrimidine compounds, compositions and methods of use |
06/28/2012 | US20120165298 Sulfonamide compounds |
06/28/2012 | US20120165278 Pyrroloquinolinyl-Pyrrolidine-2,5-Dione Compositions And Methods For Preparing And Using Same |
06/28/2012 | US20120164188 Paliperidone or a pharmaceutically acceptable salt thereof substantially free of impurities |
06/28/2012 | US20120164103 Compounds and Methods for the Treatment or Prevention of Flavivirus Infections |
06/28/2012 | US20120161612 New heterocyclic derivative and organic light emitting device using same |
06/28/2012 | CA2845524A1 Substituted methyl amines, serotonin 5-ht6 receptor antagonists, methods for the production and use thereof |
06/28/2012 | CA2822919A1 Fused heterocyclic compound and use for pest control thereof |
06/28/2012 | CA2822842A1 Faah inhibitors |
06/28/2012 | CA2822758A1 Optically active diazabicyclooctane derivative and process for preparing the same |
06/28/2012 | CA2822590A1 Heterocyclic compounds and their uses |
06/28/2012 | CA2822357A1 Hepatitis c inhibitors and uses thereof |
06/28/2012 | CA2821546A1 2-arylimidazo[1,2-b]pyridazine, 2-phenylimidazo[1,2-a]pyridine, and 2-phenylimidazo[1,2-a]pyrazine derivatives |
06/28/2012 | CA2819825A1 Compositions and methods for modulating fxr |
06/28/2012 | CA2818597A1 Quinoxalines and aza-quinoxalines as crth2 receptor modulators |
06/27/2012 | EP2468748A1 Pyrazoloquinolones are potent parp inhibitors |
06/27/2012 | EP2468744A2 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
06/27/2012 | EP2468731A1 Cyclic azine derivatives, processes for producing these, and organic electroluminescent element containing these as component |
06/27/2012 | EP2467383A1 Heterocyclic oxime compounds |
06/27/2012 | EP2467382A1 Amino tetrahydro-pyridopyrimidine pde10 inhibitors |
06/27/2012 | EP2467364A2 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation |
06/27/2012 | EP2467353A1 Fluorinated aromatic materials and their use in optoelectronics |
06/27/2012 | EP2467141A1 Heterocyclic compounds and uses thereof |
06/27/2012 | EP2222166B1 Heterocyclic kinase inhibitors |
06/27/2012 | EP2215089B1 [1h- pyrazolo [3, 4-b]pyridine-4-yl]-phenyle or -pyridin-2-yle derivatives as protein kinase c-theta |
06/27/2012 | EP2013170B1 4-squarylpiperazine derivatives as antiviral agents |
06/27/2012 | EP2007765B1 Immunopotentiating compounds |
06/27/2012 | EP1999120B1 Benzothiazoles having histamine h3 receptor activity |
06/27/2012 | EP1549313B1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
06/27/2012 | CN1882587B Use of tricyclic compounds as glycine transport inhibitors |
06/27/2012 | CN1826323B 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators |
06/27/2012 | CN102516263A Spirotricyclic compound, its preparation method, and pharmaceutical composition containing it as well as application thereof |
06/27/2012 | CN102516244A Hexa-atomic aromatic heterocyclic imidazole mercapto-acetamide derivative, and preparation method and application thereof |
06/27/2012 | CN102516243A Chemical synthesis method of 8-benzyl-2, 8-diazabicyclo (4, 3, 0) nonane |
06/27/2012 | CN102516169A Method for preparing polysubstituted isoquinoline and heterocyclic pyridine derivants |
06/27/2012 | CN102516155A 2-alkoxy-4-halo-6-alkylphenyl-substituted (hetero)cyclic ketoenols |
06/27/2012 | CN102516000A Method for synthesizing aryl trifluoromethyl sulphydryl compound |
06/27/2012 | CN101903339B Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
06/27/2012 | CN101781299B One-pot synthesis method for key intermediate of carbostyril medicaments |
06/27/2012 | CN101679416B Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza- spiro[3, 4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceu |
06/27/2012 | CN101663303B Heteroaromatic compounds, the preparation method and the use thereof |
06/27/2012 | CN101501002B Non-nucleoside reverse transcriptase inhibitors |
06/27/2012 | CN101454319B Novel heterocyclic compound or salt thereof and intermediate thereof |
06/27/2012 | CN101242833B Pyrrolopyridine derivatives and use of same as PPAR receptor modulators |
06/27/2012 | CN101103022B New carboxylic acid amide used as XA inhititor |
06/26/2012 | US8207340 Imidazopyridinyl benzamide mitotic kinesin inhibitors |
06/26/2012 | US8207339 Process for preparing Moxifloxacin and salts thereof |
06/26/2012 | US8207331 Benzazepine derivatives for the treatment of neurological disorders |
06/26/2012 | US8207190 Enantiomer of tenatoprazole and the use thereof in therapy |
06/26/2012 | US8207189 Compound having affinity for amyloid |
06/26/2012 | US8207187 Use of pyrroloquinoline compounds to kill clinically latent microorganisms |
06/26/2012 | US8207183 Inhibitors of IAP |
06/26/2012 | US8207180 Tricyclic indoles and (4,5-dihydro) indoles |
06/26/2012 | US8207176 Compounds |
06/26/2012 | US8207173 Benzimidazoles and analogs thereof as antivirals |
06/26/2012 | US8207172 Pyrimidinothienoindazoles useful for the treatment of hyperproliferative disorders |
06/26/2012 | CA2504941C 3-substituted-6-aryl pyridines |
06/26/2012 | CA2384421C Fluorescent compounds for use in industrial water systems |
06/21/2012 | WO2012083122A1 Inhibitors of influenza viruses replication |
06/21/2012 | WO2012083121A1 Inhibitors of influenza viruses replication |
06/21/2012 | WO2012083117A1 Inhibitors of influenza viruses replication |
06/21/2012 | WO2012083112A2 Cyp11b, cyp17, and/or cyp21 inhibitors |
06/21/2012 | WO2012082689A1 SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1,2-a]PYRIDINE-3-CARBOXAMIDE COMPOUNDS AS TYPE III RECEPTOR TYROSINE KINASE INHIBITORS |